These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 26455545)

  • 21. Diagnostic Challenges and Radiological Spectrum of Tumefactive Multiple Sclerosis: A Case Report Study.
    Muddassir R; Badirah SB; Alshahrani GM; Eltahan AA
    Cureus; 2022 Nov; 14(11):e31899. PubMed ID: 36579264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MRI Findings in Tumefactive Demyelinating Lesions: A Systematic Review and Meta-Analysis.
    Suh CH; Kim HS; Jung SC; Choi CG; Kim SJ
    AJNR Am J Neuroradiol; 2018 Sep; 39(9):1643-1649. PubMed ID: 30115676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary central nervous system lymphoma with preceding spontaneous pseudotumoral demyelination in an immunocompetent adult patient: A case report and literature review.
    Yamamoto J; Shimajiri S; Nakano Y; Nishizawa S
    Oncol Lett; 2014 Jun; 7(6):1835-1838. PubMed ID: 24932243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paraneoplastic tumefactive demyelination in a 47-year-old man with underlying seminoma.
    Van Haver AS; Debruyne F; Sanders K; Verstappen A
    Mult Scler Relat Disord; 2020 Jul; 42():102060. PubMed ID: 32217464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraoperative rapid diagnosis of primary central nervous system lymphomas: advantages and pitfalls.
    Sugita Y; Terasaki M; Nakashima S; Ohshima K; Morioka M; Abe H
    Neuropathology; 2014 Oct; 34(5):438-45. PubMed ID: 24750231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroimaging and clinicopathological differences between tumefactive demyelinating lesions and sentinel lesions of primary central nervous system lymphoma.
    Sun C; Han J; Lin Y; Qi X; Li C; Liu J; Qiu F
    Front Immunol; 2022; 13():986473. PubMed ID: 36059526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MRI findings of primary CNS lymphoma in 26 immunocompetent patients.
    Zhang D; Hu LB; Henning TD; Ravarani EM; Zou LG; Feng XY; Wang WX; Wen L
    Korean J Radiol; 2010; 11(3):269-77. PubMed ID: 20461180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Case of 55-year-old female with primary central nervous system lymphoma, presenting with brain and eye lesions and long-term relapsing/remitting course].
    Sasaki T; Nakayama T; Kitamura M; Kakuta Y; Imafuku I
    Rinsho Shinkeigaku; 2015; 55(8):567-72. PubMed ID: 26156255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumefactive demyelinating lesions: conventional and advanced magnetic resonance imaging.
    Enzinger C; Strasser-Fuchs S; Ropele S; Kapeller P; Kleinert R; Fazekas F
    Mult Scler; 2005 Apr; 11(2):135-9. PubMed ID: 15794384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paraneoplastic tumefactive demyelination with underlying combined germ cell cancer.
    Broadfoot JR; Archer HA; Coulthard E; Appelman AP; Sutak J; Braybrooke JP; Love S
    Pract Neurol; 2015 Dec; 15(6):451-5. PubMed ID: 26088612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and imaging correlation in patients with pathologically confirmed tumefactive demyelinating lesions.
    Tremblay MA; Villanueva-Meyer JE; Cha S; Tihan T; Gelfand JM
    J Neurol Sci; 2017 Oct; 381():83-87. PubMed ID: 28991721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can morphological MRI differentiate between primary central nervous system lymphoma and glioblastoma?
    Malikova H; Koubska E; Weichet J; Klener J; Rulseh A; Liscak R; Vojtech Z
    Cancer Imaging; 2016 Nov; 16(1):40. PubMed ID: 27894359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Open ring enhancement in atypical brain demyelination.
    Javalkar V; Manix M; Wilson J; Nanda A
    J Clin Neurosci; 2012 Jun; 19(6):910-2. PubMed ID: 22342238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Multiple Faces of Nervous System Lymphoma. Atypical Magnetic Resonance Imaging Features and Contribution of the Advanced Imaging.
    Jiménez de la Peña MD; Vicente LG; Alonso RC; Cabero SF; Suárez AM; de Vega VM
    Curr Probl Diagn Radiol; 2017; 46(2):136-145. PubMed ID: 27475832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinguishing primary central nervous system lymphoma from other central nervous system diseases: a neurosurgical perspective on diagnostic dilemmas and approaches.
    Hunt MA; Jahnke K; Murillo TP; Neuwelt EA
    Neurosurg Focus; 2006 Nov; 21(5):E3. PubMed ID: 17134119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relapsing Tumefactive Demyelination: A Case Report.
    Omerhodžić I; Džurlić A; Lisica D; Mahmutbegović N; Nikšić M; Bilalović N; Suljić E
    Acta Med Acad; 2018 Nov; 47(2):193-198. PubMed ID: 30585071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study.
    Siri A; Carra-Dalliere C; Ayrignac X; Pelletier J; Audoin B; Pittion-Vouyovitch S; Debouverie M; Lionnet C; Viala F; Sablot D; Brassat D; Ouallet JC; Ruet A; Brochet B; Taillandier L; Bauchet L; Derache N; Defer G; Cabre P; de Seze J; Lebrun Frenay C; Cohen M; Labauge P
    J Neurol; 2015 Jul; 262(7):1637-45. PubMed ID: 25929666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [An autopsy case of primary central nervous system lymphoma with diffuse intracerebral lesion].
    Kazahaya Y; Doi A; Hamaya K
    No To Shinkei; 1992 Jan; 44(1):65-70. PubMed ID: 1562388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solitary Tumefactive Demyelinating Lesions in Children: Clinical and Magnetic Resonance Imaging Features, Pathologic Characteristics, and Outcomes.
    Frankl S; Viaene A; Vossough A; Waldman A; Hopkins S; Banwell B
    Pediatr Neurol; 2024 Aug; 157():141-150. PubMed ID: 38917518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumefactive demyelination and glioblastoma: a rare collision lesion.
    Roemer SF; Scheithauer BW; Varnavas GG; Lucchinetti CF
    Clin Neuropathol; 2011; 30(4):186-91. PubMed ID: 21726504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.